VisionSys AI Inc. Announces Pricing of $3 Million Registered Direct Offering

VisionSys AI (NASDAQ: VSA) announced a registered direct offering of 3,000,000 ADS at $1.00 per ADS, with gross proceeds of approximately $3.0 million before fees.

Rhea-AI Summary

VisionSys AI (NASDAQ: VSA) announced a registered direct offering of 3,000,000 ADS at $1.00 per ADS, with gross proceeds of approximately $3.0 million before fees. The offering is expected to close on or about March 30, 2026, subject to customary closing conditions.

Univest Securities is acting as sole placement agent. The offering is being made under a Form F-3 shelf registration that became effective on August 21, 2025; a final prospectus supplement will be filed with the SEC and made available to investors.

Argus Mar 27 session

-44.51% close to close 26.0x rel. volume Open Argus

Details

News Market Reaction – VSA

On Mar 27, the day this news came out, VSA closed 44.51% below the previous close. That session’s volume was 26.0x the stock’s average daily volume.

Data tracked by StockTitan Argus for the Mar 27 session.

Key Figures

ADS offered: 3,000,000 ADS Offering price: $1.00 per ADS Gross proceeds: $3 million +3 more

ADS offered

3,000,000 ADS

Size of registered direct offering

Offering price

$1.00 per ADS

Registered direct offering price

Gross proceeds

$3 million

Estimated before fees and expenses

Form F-3 file number

333-284305

Shelf registration statement referenced for this offering

Shelf effectiveness date

August 21, 2025

Date Form F-3 became effective

Expected closing date

March 30, 2026

Anticipated close of registered direct offering

Previous Offering,AI Reports

1 past event · Latest: Nov 12

Same Type 1 event

1. Nov 12

   Registered direct offering

   24h Move

   -77.7%

   Announced $12M ADS and warrant financing at $1.30 per unit with resets.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

registered direct offering, american depositary shares, pre-funded warrants, shelf registration statement, +4 more

8 terms

registered direct offering financial

"for the purchase and sale of 3,000,000 American Depositary Shares... from the registered direct offering are estimated"

A registered direct offering is a way for a company to sell new shares of its stock directly to select investors with regulatory approval. This method allows the company to raise funds quickly and efficiently without needing a public auction, similar to offering exclusive access to a limited number of buyers. For investors, it often provides an opportunity to purchase shares at a favorable price, while giving the company immediate access to capital.

american depositary shares financial

"for the purchase and sale of 3,000,000 American Depositary Shares (“ADS”) (or pre-funded warrants"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

pre-funded warrants financial

"3,000,000 American Depositary Shares (“ADS”) (or pre-funded warrants in lieu of ADS)"

Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.

shelf registration statement regulatory

"The registered direct offering is being made pursuant to a shelf registration statement on Form F-3"

A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.

form f-3 regulatory

"shelf registration statement on Form F-3 (File No. 333-284305) previously filed"

Form F-3 is a U.S. securities filing that lets eligible foreign companies pre-register and then quickly sell shares or other securities to raise money, because they already meet ongoing reporting and size tests. For investors it signals that the company is up-to-date with regulatory disclosure and has an efficient way to issue new securities — similar to a pre-approved credit line — which can mean faster capital raises but also potential dilution of existing holdings.

prospectus supplement regulatory

"A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

placement agent financial

"Univest Securities, LLC is acting as the sole placement agent."

A placement agent is a professional or firm that helps organizations raise money from investors, such as individuals, institutions, or funds. They act like matchmakers, connecting those seeking investments with the right investors and guiding the process to ensure successful funding. For investors, they can provide access to exclusive opportunities and help navigate complex fundraising efforts.

securities and exchange commission regulatory

"previously filed by the Company with the U.S. Securities and Exchange Commission (“SEC”)"

A national government agency that enforces rules for buying, selling and disclosing information about stocks and other investments, acting like a referee and scorekeeper for financial markets. It requires companies to share clear, regular financial and business information and investigates fraud or rule-breaking, which matters to investors because those rules and disclosures help ensure fair prices, reduce hidden risks and make it easier to compare investment choices.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) --   VisionSys AI Inc. (NASDAQ: VSA) ("VisionSys" or the "Company"), an emerging technology services company specializing in brain-machine interaction businesses leveraging core algorithms and related software and hardware systems, today announced that it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 3,000,000 American Depositary Shares (“ADS”) (or pre-funded warrants in lieu of ADS), at an offering price of $1.00 per ADS.

The gross proceeds to the Company from the registered direct offering are estimated to be approximately $3 million before deducting the placement agent’s fees and other estimated offering expenses. The offering is expected to close on or about March 30, 2026, subject to the satisfaction of customary closing conditions.

Univest Securities, LLC is acting as the sole placement agent.

The registered direct offering is being made pursuant to a shelf registration statement on Form F-3 (File No. 333-284305) previously filed by the Company with the U.S. Securities and Exchange Commission (“SEC”) and became effective by on August 21, 2025. A final prospectus supplement and accompanying prospectus describing the terms of the proposed offering will be filed with the SEC and will be available on the SEC's website located at http://www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus may be obtained, when available, by contacting Univest Securities, LLC at info@univest.us, or by calling +1 (212) 343-8888.

This press release does not constitute an offer to sell or the solicitation of an offer to buy, nor will there be any sales of such securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. Copies of the prospectus supplement relating to the registered direct offering, together with the accompanying base prospectus will be filed by the Company and, upon filing, can be obtained at the SEC's website at www.sec.gov.

About VisionSys AI Inc.

VisionSys AI Inc. (NASDAQ: VSA) is an emerging technology services company, specializing in brain-machine interaction businesses leveraging core algorithms and related software and hardware systems. The Company is dedicated to advancing AI-powered healthcare and biotech solutions that transform industries. Its mission is to empower individuals and organizations through intelligent systems, bridging innovation with real-world impact to create a smarter, more connected future.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on current expectations and projections about future events and financial trends that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can identify these forward-looking statements by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. The Company undertakes no obligation to update forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and in its other filings with the U.S. Securities and Exchange Commission.

Investor Relations Contact:
Matthew Abenante, IRC
President
Strategic Investor Relations, LLC
Tel: 347-947-2093
Email: matthew@strategic-ir.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is VisionSys AI (VSA) selling in the March 2026 registered direct offering?

VisionSys AI is offering 3,000,000 American Depositary Shares (ADS) at $1.00 per ADS. According to the company, the gross proceeds are expected to be approximately $3.0 million before fees and expenses.

When is the VisionSys AI (VSA) registered direct offering expected to close?

The offering is expected to close on or about March 30, 2026, subject to customary closing conditions. According to the company, closing is conditioned on satisfaction of standard transactional requirements.

Who is handling the placement of VisionSys AI (VSA) securities in the offering?

Univest Securities, LLC is acting as the sole placement agent for the transaction. According to the company, inquiries and prospectus requests may be directed to Univest Securities.

How much capital will VisionSys AI (VSA) raise from the registered direct offering?

The company expects gross proceeds of approximately $3.0 million before deducting placement agent fees and offering expenses. According to the company, net proceeds will be lower after customary fees and expenses.

Under what registration is VisionSys AI (VSA) conducting the March 2026 offering?

The offering is being made under a Form F-3 shelf registration that became effective on August 21, 2025. According to the company, a final prospectus supplement will be filed with the SEC.

Where can investors obtain the VisionSys AI (VSA) prospectus for the registered direct offering?

Investors can obtain the final prospectus supplement and base prospectus on the SEC website (www.sec.gov) or by contacting Univest Securities. According to the company, electronic copies will be available when filed.